Search results
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 2 days agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com
Investing.com· 2 weeks agoIn a recent transaction, Noubar Afeyan, a director at Moderna , Inc. (NASDAQ:MRNA), sold a...
Moderna halts vaccine plant in Africa amid dwindling orders - The Boston Globe
The Boston Globe· 2 weeks agoModerna has paused its efforts to build an mRNA manufacturing facility in Kenya while it determines...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 16 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges
CNBC· 2 weeks agoModerna on Thursday said it has paused plans to build a vaccine-manufacturing site in Kenya after a...
Moderna paused its plans for a facility in Kenya because COVID-19 vaccine demand has plummeted
Quartz· 2 weeks agoThe Massachusetts-based vaccine maker says the continent’s uptake of COVID-19 vaccines is no longer...
New studies point to safety of COVID vaccines, but leave questions unanswered
KARE 11 Minneapolis-St. Paul· 9 hours agoAfter more than 13 billion COVID vaccines given around the world, the largest studies to date point...
Moderna seals vaccine deal with Brazil's Health Ministry By Investing.com
Investing.com· 3 days agoThe agreement comes on the heels of the Brazilian Health Regulatory Agency's approval of the vaccine...
Moderna turns to AI to change how its employees work
BioPharma Dive via Yahoo Finance· 23 hours agoThe new agreement allows the biotech’s staff to build their own GPTs for specific purposes. For example, a pilot tool called Dose ID is designed to...
Cerity Partners LLC Grows Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 hours agoCerity Partners LLC increased its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 106.6% during the 4th quarter, according to the company in its most recent ...